| 1 |
王明月，张丽娜，曲利娟. 额部黏液炎性纤维母细胞性肉瘤1例[J]. 临床与实验病理学杂志，2020, 36(7): 873-875.
|
| 2 |
谢军伟，毛宇强，赵振坤，等. 复发性胸壁来源炎性肌纤维母细胞瘤一例[J/CD]. 中华肺部疾病杂志(电子版), 2019, 12(3): 390-391.
|
| 3 |
李正金，王丽霞，李耀康，等. 黏液炎症性纤维母细胞肉瘤临床病理分析[J]. 海南医学，2017, 28(24): 4079-4080.
|
| 4 |
Wangsiricharoen S, Ali SZ, Wakely PE Jr. Cytopathology of myxoinflammatory fibroblastic sarcoma: a series of eight cases and review of the literature[J]. J Am Soc Cytopathol, 2021, 10(3): 310-320.
|
| 5 |
Boran Ç，Kilitci A, Ahsen H, et al. The first case of myxoinflammatory fibroblastic sarcoma affecting the maxillary bone[J]. Int J Health Sci (Qassim), 2022, 16(2): 37-39.
|
| 6 |
Wei C, Yang X, Guo P, et al. Myxoinflammatory fibroblastic sarcoma of the parotid gland: first case report and literature review[J]. Front Med (Lausanne), 2022, 9: 833822.
|
| 7 |
姜惠峰，廖松林. 软组织及骨肿瘤分类(2002)[J]. 诊断病理学杂志，2004, 11(2): 126-127，104.
|
| 8 |
Jo VY, Doyle LA. Refinements in sarcoma classification in the current 2013 world health organization classification of tumours of soft tissue and bone[J]. Surg Oncol Clin N Am, 2016, 25(4): 621-643.
|
| 9 |
Kao YC, Ranucci V, Zhang L, et al. Recurrent BRAF gene rearrangements in myxoinflammatory fibroblastic sarcomas, but not hemosiderotic fibrolipomatous tumors[J]. Am J Surg Pathol, 2017, 41(11): 1456-1465.
|
| 10 |
Suster D, Michal M, Huang H, et al. Myxoinflammatory fibroblastic sarcoma: an immunohistochemical and molecular genetic study of 73 cases[J]. Mod Pathol, 2020, 33(12): 2520-2533.
|
| 11 |
Arbajian E, Hofvander J, Magnusson L, et al. Deep sequencing of myxoinflammatory fibroblastic sarcoma[J]. Genes Chromosomes Cancer, 2020, 59(5): 309-317.
|
| 12 |
Klubícková N, Agaimy A, Hájková V, et al. RNA-sequencing of myxoinflammatory fibroblastic sarcomas reveals a novel SND1：：BRAF fusion and 3 different molecular aberrations with the potential to upregulate the TEAD1 gene including SEC23IP：：VGLL3 and TEAD1：：MRTFB gene fusions[J]. Virchows Arch, 2022, 481(4): 613-620.
|
| 13 |
Hallor KH, Sciot R, Staaf J, et al. Two genetic pathways, t(1；10) and amplification of 3p11-12, in myxoinflammatory fibroblastic sarcoma, haemosiderotic fibrolipomatous tumour, and morphologically similar lesions[J]. J Pathol, 2009, 217(5): 716-727.
|
| 14 |
史丽芸，张 荣，胡雪娥，等. 黏液纤维肉瘤5例临床病理分析[J]. 中国临床研究，2020, 33(12): 1698-1701.
|
| 15 |
罗 容，胡培安，解添淞，等. 黏液纤维肉瘤影像学表现、临床特征及病理学的相关性研究[J]. 中国癌症杂志，2021, 31(8): 734-739.
|
| 16 |
Lopez-Nunez O, John I, Panasiti RN, et al. Infantile inflammatory myofibroblastic tumors: clinicopathological and molecular characterization of 12 cases[J]. Mod Pathol, 2020, 33(4): 576-590.
|
| 17 |
丁 一，杨合英，张 大，等. 儿童及青少年炎性肌纤维母细胞瘤临床分析[J]. 中华实用儿科临床杂志，2019, 34(8): 623-626.
|
| 18 |
刘 娟，朱 佳，王 娟，等. 儿童和青少年炎性肌纤维母细胞瘤临床病理特征及生存分析[J]. 中国小儿血液与肿瘤杂志，2022, 27(1): 31-35.
|
| 19 |
李逍山，何效娥，贺 震，等. 黏液性脂肪肉瘤1例[J]. 临床肺科杂志，2022, 27(8): 1292-1294.
|
| 20 |
Jo U, Roh J, Song MJ, et al. NY-ESO-1 as a diagnostic and prognostic marker for myxoid liposarcoma[J]. Am J Transl Res, 2022, 14(2): 1268-1278.
|
| 21 |
詹 媛，江锦良，蔡 勇. 低度恶性纤维黏液样肉瘤3例临床病理分析[J]. 临床与实验病理学杂志，2020, 36(2): 206-208.
|
| 22 |
Saab-Chalhoub MW, Al-Rohil RN. Low-grade fibromyxoid sarcoma of acral sites: Case report and literature review[J]. J Cutan Pathol, 2019, 46(4): 271-276.
|
| 23 |
胡雪娥，史丽芸，张 荣，等. 黏液炎性纤维母细胞肉瘤1例临床病理分析及文献复习[J]. 中国临床研究，2021, 34(12): 1684-1686.
|
| 24 |
罗 雁，安 宁，康雅琼，等. 黏液炎性纤维母细胞性肉瘤合并脊柱旁转移病例的分析[J]. 甘肃医药，2021, 40(3): 214-216.
|
| 25 |
徐作佼，高素美，王振华，等. 黏液炎性纤维母细胞性肉瘤一例[J]. 中国麻风皮肤病杂志，2022, 38(12): 895-897.
|